Microvesicle-delivery miR-150 promotes tumorigenesis by up-regulating VEGF, and the neutralization of miR-150 attenuate tumor development

Protein and Cell

Volumn 4, Issue 12, 2013, Pages 932-941

  Liu, Yuchen ^a   Zhao, Luming ^a   Li, Dameng ^a   Yin, Yuan ^b   Zhang, Chen Yu ^a   Li, Jing ^a   Zhang, Yujing ^a  

^a NANJING UNIVERSITY   (China)

^b Soochow University   (China)

Author keywords

attenuation; microvesicle; miR 150; neutralization; tumorigenesis; VEGF

Indexed keywords

CD31 ANTIGEN; COMPLEMENTARY RNA; MICRORNA; MICRORNA 150; UNCLASSIFIED DRUG; VASCULOTROPIN;

ANGIOGENESIS; ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATTENUATION; CARCINOGENESIS; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; MACROPHAGE; MALE; MEMBRANE VESICLE; MICROVESICLE; MOUSE; NEOPLASM; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SARCOMA CELL; TUMOR ASSOCIATED LEUKOCYTE; TUMOR VOLUME; UPREGULATION; WESTERN BLOTTING;

ANIMALS; CARCINOGENESIS; CELL LINE, TUMOR; EXOSOMES; HEK293 CELLS; HETEROGRAFTS; HUMANS; MACROPHAGES; MALE; MICE; MICE, INBRED C57BL; MICRORNAS; NEOPLASM TRANSPLANTATION; RNA, ANTISENSE; UP-REGULATION; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84890107684     PISSN: 1674800X     EISSN: 16748018     Source Type: Journal    
DOI: 10.1007/s13238-013-3092-z     Document Type: Article

References (36)

1. Alvarez-Erviti, L., Seow, Y., Yin, H., Betts, C., Lakhal, S., and Wood, M. J. (2011). Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes. Nat Biotechnol 29, 341-345.
2. Baek, J. H., Mahon, P. C., Oh, J., Kelly, B., Krishnamachary, B., Pearson, M., Chan, D. A., Giaccia, A. J., and Semenza, G. L. (2005). OS-9 interacts with hypoxia-inducible factor 1alpha and prolyl hydroxylases to promote oxygen-dependent degradation of HIF-1alpha. Mol Cell 17, 503-512.
3. Bartel, D. P. (2004). MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116, 281-297.
4. Bingle, L., Brown, N. J., and Lewis, C. E. (2002). The role of tumourassociated macrophages in tumour progression: implications for new anticancer therapies. J Pathol 196, 254-265.
5. Bolat, F., Kayaselcuk, F., Nursal, T. Z., Yagmurdur, M. C., Bal, N., and Demirhan, B. (2006). Microvessel density, VEGF expression, and tumor-associated macrophages in breast tumors: correlations with prognostic parameters. J Exp Clin Cancer Res 25, 365-372.
6. Brahimi-Horn, C., and Pouyssegur, J. (2006). The role of the hypoxiainducible factor in tumor metabolism growth and invasion. Bulletin du cancer 93, E73-80.
7. Chen, X., Liang, H., Zhang, J., Zen, K., and Zhang, C. Y. (2012). Secreted microRNAs: a new form of i ntercellular communication. Trends Cell Biol 22, 125-132.
8. Coffelt, S. B., Hughes, R., and Lewis, C. E. (2009). Tumor-associated macrophages: effectors of angiogenesis and tumor progression. Biochim Biophys Acta 1796, 11-18.
9. Colla, S., Tagliaferri, S., Morandi, F., Lunghi, P., Donofrio, G., Martorana, D., Mancini, C., Lazzaretti, M., Mazzera, L., Ravanetti, L., et al. (2007). The new tumor-suppressor gene inhibitor of growth family member 4 (ING4) regulates the production of proangiogenic molecules by myeloma cells and suppresses hypoxia-inducible factor-1 alpha (HIF-1alpha) activity: involvement in myeloma-induced angiogenesis. Blood 110, 4464-4475.
10. Cristofanilli, M., Charnsangavej, C., and Hortobagyi, G. N. (2002). Angiogenesis modulation in cancer research: novel clinical approaches. Nat Rev Drug Discov 1, 415-426.
11. Esquela-Kerscher, A., and Slack, F. J. (2006). Oncomirs-microRNAs with a role in cancer. Nat Rev Cancer 6, 259-269.
12. Ferrara, N. (2010). Pathways mediating VEGF-independent tumor angiogenesis. Cytokine Growth Factor Rev 21, 21-26.
13. Ferrara, N., Gerber, H. P., and LeCouter, J. (2003). The biology of VEGF and its receptors. Nat Med 9, 669-676.
14. Folkman, J. (2007). Angiogenesis: an organizing principle for drug discovery? Nat Rev Drug Discov 6, 273-286.
15. Fukuda, K., Kobayashi, A., and Watabe, K. (2012). The role of tumorassociated macrophage in tumor progression. Front Biosci (Schol Ed) 4, 787-798.
16. Goga, A., and Benz, C. (2007). Anti-oncomir suppression of tumor phenotypes. Mol Interv 7, 199-202, 180.
17. Hanahan, D., and Coussens, L. M. (2012). Accessories to the crime: functions of cells recruited to the tumor microenvironment. Cancer Cell 21, 309-322.
18. Kim, K. J., Li, B., Winer, J., Armanini, M., Gillett, N., Phillips, H. S., and Ferrara, N. (1993). Inhibition of vascular endothelial growth factorinduced angiogenesis suppresses tumour growth in vivo. Nature 362, 841-844.
19. Kota, J., Chivukula, R. R., O'Donnell, K. A., Wentzel, E. A., Montgomery, C. L., Hwang, H. W., Chang, T. C., Vivekanandan, P., Torbenson, M., Clark, K. R., et al. (2009). Therapeutic microRNA delivery suppresses tumorigenesis in a murine liver cancer model. Cell 137, 1005-1017.
20. Lewis, C. E., Leek, R., Harris, A., and McGee, J. O. (1995). Cytokine regulation of angiogenesis in breast cancer: the role of tumorassociated macrophages. J Leukoc Biol 57, 747-751.
21. Lewis, C. E., and Pollard, J. W. (2006). Distinct role of macrophages in different tumor microenvironments. Cancer Res 66, 605-612.
22. Lin, E. Y., Nguyen, A. V., Russell, R. G., and Pollard, J. W. (2001). Colony-stimulating factor 1 promotes progression of mammary tumors to malignancy. J Exp Med 193, 727-740.
23. Lin, E. Y., and Pollard, J. W. (2007). Tumor-associated macrophages press the angiogenic switch in breast cancer. Cancer Res 67, 5064-5066.
24. Luo, Y., Zhou, H., Krueger, J., Kaplan, C., Lee, S. H., Dolman, C., Markowitz, D., Wu, W., Liu, C., Reisfeld, R. A., et al. (2006). Targeting tumor-associated macrophages as a novel strategy against breast cancer. J Clin Invest 116, 2132-2141.
25. McDonnell, C. O., Bouchier-Hayes, D. J., Toomey, D., Foley, D., Kay, E. W., Leen, E., and Walsh, T. N. (2003). Effect of neoadjuvant chemoradiotherapy on angiogenesis in oesophageal cancer. Br J Surg 90, 1373-1378.
26. Millan Nunez-Cortes, J. (1991). Angiogenesis: a crucial element in tumor development. An Med Interna 8, 369-371.
27. Murdoch, C., Muthana, M., Coffelt, S. B., and Lewis, C. E. (2008). The role of myeloid cells in the promotion of tumour angiogenesis. Nat Rev Cancer 8, 618-631.
28. Ozer, A., Wu, L. C., and Bruick, R. K. (2005). The candidate tumor suppressor ING4 represses activation of the hypoxia inducible factor (HIF). Proc Natl Acad Sci U S A 102, 7481-7486.
29. Presta, L. G., Chen, H., O'Connor, S. J., Chisholm, V., Meng, Y. G., Krummen, L., Winkler, M., and Ferrara, N. (1997). Humanization of an anti-vascular endothelial growth factor monoclonal antibody for the therapy of solid tumors and other disorders. Cancer Res 57, 4593-4599.
30. Qian, B. Z., and Pollard, J. W. (2010). Macrophage diversity enhances tumor progression and metastasis. Cell 141, 39-51.
31. Rolny, C., Mazzone, M., Tugues, S., Laoui, D., Johansson, I., Coulon, C., Squadrito, M. L., Segura, I., Li, X., Knevels, E., et al. (2011). HRG inhibits tumor growth and metastasis by inducing macrophage polarization and vessel normalization through downregulation of PlGF. Cancer Cell 19, 31-44.
32. Stockmann, C., Doedens, A., Weidemann, A., Zhang, N., Takeda, N., Greenberg, J. I., Cheresh, D. A., and Johnson, R. S. (2008). Deletion of vascular endothelial growth factor in myeloid cells accelerates tumorigenesis. Nature 456, 814-818.
33. Valadi, H., Ekstrom, K., Bossios, A., Sjostrand, M., Lee, J. J., and Lotvall, J. O. (2007). Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat Cell Biol 9, 654-659.
34. van den Boorn, J. G., Schlee, M., Coch, C., and Hartmann, G. (2011). SiRNA delivery with exosome nanoparticles. Nat Biotechnol 29, 325-326.
35. Warren, R. S., Yuan, H., Matli, M. R., Gillett, N. A., and Ferrara, N. (1995). Regulation by vascular endothelial growth factor of human colon cancer tumorigenesis in a mouse model of experimental liver metastasis. J Clin Invest 95, 1789-1797.
36. Zhang, Y., Liu, D., Chen, X., Li, J., Li, L., Bian, Z., Sun, F., Lu, J., Yin, Y., Cai, X., et al. (2010). Secreted monocytic miR-150 enhances targeted endothelial cell migration. Mol Cell 39, 133-144.